[1] |
Williams B, Bernstein W. Review of venoarterial extracorporeal membrane oxygenation and development of intracardiac thrombosis in adult cardiothoracic patients [J]. J Extra Corpor Technol, 2016, 48(4): 162-167.
|
[2] |
Boulate D, Luyt CE, Pozzi M, et al. Acute lung injury after mechanical circulatory support implantation in patients on extracorporeal life support: an unrecognized problem [J]. Eur J Cardiothorac Surg, 2013, 44(3): 544-549; discussion 549-550.
|
[3] |
Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock [J]. N Engl J Med, 2012, 367(14): 1287-1296.
|
[4] |
Lüsebrink E, Orban M, Kupka D, et al. Prevention and treatment of pulmonary congestion in patients undergoing venoarterial extracorporeal membrane oxygenation for cardiogenic shock [J]. Eur Heart J, 2020, 41(38): 3753-3761.
|
[5] |
Ostadal P, Mlcek M, Kruger A, et al. Increasing venoarterial extracorporeal membrane oxygenation flow negatively affects left ventricular performance in a porcine model of cardiogenic shock [J]. J Transl Med, 2015, 13: 266.
|
[6] |
Rao P, Khalpey Z, Smith R, et al. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest [J]. Circ Heart Fail, 2018, 11(9): e004905.
|
[7] |
Burkhoff D, Sayer G, Doshi D, et al. Hemodynamics of mechanical circulatory support [J]. J Am Coll Cardiol, 2015, 66(23): 2663-2674.
|
[8] |
Wilson J, Fisher R, Caetano F, et al. Managing Harlequin Syndrome in VA-ECMO - do not forget the right ventricle [J]. Perfusion, 2022, 37(5): 526-529.
|
[9] |
Thiele H, Zeymer U, Akin I, et al. Extracorporeal life support in infarct-related cardiogenic shock [J]. N Engl J Med, 2023, 389(14): 1286-1297.
|
[10] |
Desch S, Zeymer U, Akin I, et al. Routine extracorporeal life support in infarct-related cardiogenic shock: 1-year results of the ECLS-SHOCK trial [J]. Eur Heart J, 2024, 45(39): 4200-4203.
|
[11] |
Kolte D, Khera S, Aronow WS, et al. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States [J]. J Am Heart Assoc, 2014, 3(1): e000590.
|
[12] |
Kunadian V, Qiu W, Ludman P, et al. Outcomes in patients with cardiogenic shock following percutaneous coronary intervention in the contemporary era: an analysis from the BCIS database (British Cardiovascular Intervention Society) [J]. JACC Cardiovasc Interv, 2014, 7(12): 1374-1385.
|
[13] |
Baran DA, Grines CL, Bailey S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019 [J]. Catheter Cardiovasc Interv, 2019, 94(1): 29-37.
|
[14] |
Del Rio-Pertuz G, Benjanuwattra J, Juarez M, et al. Efficacy of mechanical circulatory support used before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from ST-elevation myocardial infarction: a systematic review and meta-analysis [J]. Cardiovasc Revasc Med, 2022, 42: 74-83.
|
[15] |
Zeymer U, Freund A, Hochadel M, et al. Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials [J]. Lancet, 2023, 402(10410): 1338-1346.
|
[16] |
Ostadal P, Rokyta R, Karasek J, et al. Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial [J]. Circulation, 2023, 147(6): 454-464.
|
[17] |
Brunner S, Guenther S, Lackermair K, et al. Extracorporeal life support in cardiogenic shock complicating acute myocardial infarction [J]. J Am Coll Cardiol, 2019, 73(18): 2355-2357.
|
[18] |
Banning AS, Sabaté M, Orban M, et al. Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial [J]. EuroIntervention, 2023, 19(6): 482-492.
|
[19] |
Thiele H, Møller JE, Henriques J, et al. Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-up [J]. Lancet, 2024, 404(10457): 1019-1028.
|
[20] |
Hanlon-Pena PM, Quaal SJ. Intra-aortic balloon pump timing: review of evidence supporting current practice [J]. Am J Crit Care, 2011, 20(4): 323-333; quiz 334.
|
[21] |
Fujino T, Imamura T, Kinugawa K. Future perspectives of intra-aortic balloon pumping for cardiogenic shock [J]. Int Heart J, 2020, 61(3): 424-428.
|
[22] |
Zhang Q, Han Y, Sun S, et al. Mortality in cardiogenic shock patients receiving mechanical circulatory support: a network meta-analysis [J]. BMC Cardiovasc Disord, 2022, 22(1): 48.
|
[23] |
Low C, Ling RR, Lau M, et al. Mechanical circulatory support for cardiogenic shock: a network meta-analysis of randomized controlled trials and propensity score-matched studies [J]. Intensive Care Med, 2024, 50(2): 209-221.
|
[24] |
Kim MC, Lim Y, Lee SH, et al. Early left ventricular unloading or conventional approach after venoarterial extracorporeal membrane oxygenation: the EARLY-UNLOAD randomized clinical trial [J]. Circulation, 2023, 148(20): 1570-1581.
|
[25] |
Lim Y, Kim MC, Lee SH, et al. Early left ventricular unloading after venoarterial extracorporeal membrane oxygenation: 1-year outcomes of the EARLY-UNLOAD randomized clinical trial [J]. Eur Heart J Acute Cardiovasc Care, 2025, 14(4): 203-211.
|
[26] |
Glazier JJ, Kaki A. The Impella device: historical background, clinical applications and future directions [J]. Int J Angiol, 2019, 28(2): 118-123.
|
[27] |
Cappannoli L, Galli M, Zito A, et al. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs. without left ventricular unloading by Impella: a systematic review and meta-analysis [J]. Eur Heart J Qual Care Clin Outcomes, 2023, 9(4): 358-366.
|
[28] |
Schrage B, Becher PM, Bernhardt A, et al. Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an international, multicenter cohort study [J]. Circulation, 2020, 142(22): 2095-2106.
|
[29] |
Char S, Fried J, Melehy A, et al. Clinical efficacy of direct or indirect left ventricular unloading during venoarterial extracorporeal membrane oxygenation for primary cardiogenic shock [J]. J Thorac Cardiovasc Surg, 2023, 165(2): 699-707.e5.
|
[30] |
Radakovic D, Zittermann A, Rojas SV, et al. Left ventricular unloading in patients on venoarterial extracorporeal membrane oxygenation therapy in cardiogenic shock: prophylactic versus bail-out strategy [J]. Life (Basel), 2023, 13(2): 582.
|
[31] |
Møller JE, Engstrøm T, Jensen LO, et al. Microaxial flow pump or standard care in infarct-related cardiogenic shock [J]. N Engl J Med, 2024, 390(15): 1382-1393.
|
[32] |
Grandin EW, Nunez JI, Willar B, et al. Mechanical left ventricular unloading in patients undergoing venoarterial extracorporeal membrane oxygenation [J]. J Am Coll Cardiol, 2022, 79(13): 1239-1250.
|
[33] |
Rajsic S, Breitkopf R, Treml B, et al. Association of anti-factor Xa-guided anticoagulation with hemorrhage during ECMO support: A systematic review and meta-analysis [J]. Clin Cardiol, 2024, 47(5): e24273.
|
[34] |
Saracoglu A, Fawzy I, Saracoglu KT, et al. Point of care guided coagulation management in adult patients on ECMO: a systematic review and meta-analysis [J]. J Crit Care, 2024, 83: 154830.
|
[35] |
Cartwright B, Bruce HM, Kershaw G, et al. Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study [J]. Sci Rep, 2021, 11(1): 7975.
|
[36] |
Vlok R, Buscher H, Delaney A, et al. Anticoagulation and associated complications in veno-arterial extracorporeal membrane oxygenation in adult patients: a systematic review and meta-analysis [J]. Crit Care Resusc, 2024, 26(4): 332-363.
|
[37] |
Ezad SM, Ryan M, Donker DW, et al. Unloading the left ventricle in venoarterial ECMO: in whom, when, and how? [J]. Circulation, 2023, 147(16): 1237-1250.
|
[38] |
Lüsebrink E, Binzenhöfer L, Kellnar A, et al. Venting during venoarterial extracorporeal membrane oxygenation [J]. Clin Res Cardiol, 2023, 112(4): 464-505.
|
[39] |
Bréchot N, Demondion P, Santi F, et al. Intra-aortic balloon pump protects against hydrostatic pulmonary oedema during peripheral venoarterial-extracorporeal membrane oxygenation [J]. Eur Heart J Acute Cardiovasc Care, 2018, 7(1): 62-69.
|
[40] |
Aso S, Matsui H, Fushimi K, et al. The effect of intraaortic balloon pumping under venoarterial extracorporeal membrane oxygenation on mortality of cardiogenic patients: an analysis using a nationwide inpatient database [J]. Crit Care Med, 2016, 44(11): 1974-1979.
|
[41] |
Björnsdóttir B, Biancari F, Dalén M, et al. Postcardiotomy venoarterial extracorporeal membrane oxygenation with and without intra-aortic balloon pump [J]. J Cardiothorac Vasc Anesth, 2022, 36(8 Pt B): 2876-2883.
|
[42] |
Vallabhajosyula S, O'Horo JC, Antharam P, et al. Concomitant intra-aortic balloon pump use in cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation [J]. Circ Cardiovasc Interv, 2018, 11(9): e006930.
|
[43] |
Russo JJ, Aleksova N, Pitcher I, et al. Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock [J]. J Am Coll Cardiol, 2019, 73(6): 654-662.
|
[44] |
Meertens MM, Tichelbäcker T, Macherey-Meyer S, et al. Meta-analysis of extracorporeal membrane oxygenation in combination with intra-aortic balloon pump vs. extracorporeal membrane oxygenation only in patients with cardiogenic shock due to acute myocardial infarction [J]. Front Cardiovasc Med, 2022, 9: 1104357.
|
[45] |
Baran C, Ozcinar E, Kayan A, et al. Comparison of ECMO, IABP and ECMO + IABP in the postoperative period in patients with postcardiotomy shock [J]. J Cardiovasc Dev Dis, 2024, 11(9): 283.
|
[46] |
Tongers J, Sieweke JT, Kühn C, et al. Early escalation of mechanical circulatory support stabilizes and potentially rescues patients in refractory cardiogenic shock [J]. Circ Heart Fail, 2020, 13(3): e005853.
|
[47] |
Hsu HR, Sekhar P, Grover J, et al. Predictors of successful weaning from veno-arterial extracorporeal membrane oxygenation (V-A ECMO): a systematic review and meta-analysis [J]. PLoS One, 2025, 20(3): e0310289.
|
[48] |
Lee BR, Choi KH, Kim EJ, et al. VA-ECMO weaning strategy using adjusted pulse pressure by vasoactive inotropic score in AMI complicated by cardiogenic shock [J]. ESC Heart Fail, 2024, 11(5): 2749-2758.
|
[49] |
Petermichl W, Philipp A, Foltan M, et al. Long-term outcomes of out-of-center veno-arterial ECMO cannulation for cardiopulmonary failure: investigation of prognostic parameters for a decision support tool - a 16-year retrospective study [J]. Scand J Trauma Resusc Emerg Med, 2025, 33(1): 81.
|
[50] |
Bairdain S, Betit P, Craig N, et al. Diverse morbidity and mortality among infants treated with venoarterial extracorporeal membrane oxygenation [J]. Cureus, 2015, 7(4): e263.
|
[51] |
Schmidt M, Burrell A, Roberts L, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score [J]. Eur Heart J, 2015, 36(33): 2246-2256.
|
[52] |
Muller G, Flecher E, Lebreton G, et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock [J]. Intensive Care Med, 2016, 42(3): 370-378.
|
[53] |
Pabst D, Foy AJ, Peterson B, et al. Predicting survival in patients treated with extracorporeal membrane oxygenation after myocardial infarction [J]. Crit Care Med, 2018, 46(5): e359-e363.
|
[54] |
余海佳, 李静超, 宋慧慧, 等. 早期VA-ECMO支持在急诊经皮冠脉介入治疗围手术期的应用价值 [J]. 中华急诊医学杂志, 2024, 33(7): 946-954.
|